Safety and Immunogenicity of COVI-VAC, a Live Attenuated Vaccine Against COVID-19
Clinical trial NCT04619628 · COMPLETED
Trial details
- NCT number
- NCT04619628
- Sponsor
- Codagenix, Inc
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-11
- Primary completion
- 2021-06-26
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.